Vor Biopharma Statistics Share Statistics Vor Biopharma has 6.33M
shares outstanding. The number of shares has increased by 82.69%
in one year.
Shares Outstanding 6.33M Shares Change (YoY) 82.69% Shares Change (QoQ) 0.09% Owned by Institutions (%) 42.64% Shares Floating 3.94M Failed to Deliver (FTD) Shares 534,459 FTD / Avg. Volume 105.63%
Short Selling Information The latest short interest is 22.02M, so 321.94% of the outstanding
shares have been sold short.
Short Interest 22.02M Short % of Shares Out 321.94% Short % of Float 758.58% Short Ratio (days to cover) 4.62
Valuation Ratios The PE ratio is -0.65 and the forward
PE ratio is -5.88.
Vor Biopharma's PEG ratio is
0.23.
PE Ratio -0.65 Forward PE -5.88 PS Ratio 0 Forward PS 51.1 PB Ratio 0.79 P/FCF Ratio -0.76 PEG Ratio 0.23
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Vor Biopharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 5.19,
with a Debt / Equity ratio of 0.33.
Current Ratio 5.19 Quick Ratio 5.19 Debt / Equity 0.33 Debt / EBITDA -0.28 Debt / FCF -0.32 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-735.31K Employee Count 159 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 137.09% in the
last 52 weeks. The beta is 2.06, so Vor Biopharma's
price volatility has been higher than the market average.
Beta 2.06 52-Week Price Change 137.09% 50-Day Moving Average 39.16 200-Day Moving Average 23.95 Relative Strength Index (RSI) 46.2 Average Volume (20 Days) 505,984
Income Statement
Revenue n/a Gross Profit -3.53M Operating Income -121.19M Net Income -116.91M EBITDA -113.39M EBIT -116.91M Earnings Per Share (EPS) -34
Full Income Statement Balance Sheet The company has 81.95M in cash and 31.83M in
debt, giving a net cash position of 50.12M.
Cash & Cash Equivalents 81.95M Total Debt 31.83M Net Cash 50.12M Retained Earnings -456.99M Total Assets 205.37M Working Capital 146.15M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -99.66M
and capital expenditures -229K, giving a free cash flow of -99.89M.
Operating Cash Flow -99.66M Capital Expenditures -229K Free Cash Flow -99.89M FCF Per Share -29.08
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields VOR does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for VOR is $80,
which is 138% higher than the current price. The consensus rating is "Hold".
Price Target $80 Price Target Difference 138% Analyst Consensus Hold Analyst Count 6
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 19, 2025. It was a
backward
split with a ratio of 1:20.
Last Split Date Sep 19, 2025 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -17.93 Piotroski F-Score 1
